Swedish Orphan Biovitrum AB (publ)
Change company Symbol lookup
Select an option...
BIOVF Swedish Orphan Biovitrum AB (publ)
WECMF WeCommerce Holdings Ltd
STX Seagate Technology Holdings PLC
HLAHU Hamilton Lane Alliance Holdings I Inc
GUERF Guerbet SA
BTCM BIT Mining Ltd
ATHE Alterity Therapeutics Ltd
EPR EPR Properties
LUMN Lumen Technologies Inc
SEMR SEMrush Holdings Inc
Go


Based in Sweden
Company profile

Swedish Orphan Biovitrum publ AB is a Sweden-based pharmaceutical company. The Company develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company’s product portfolio is divided into three business segments: the Core Products segment offers pharmaceuticals within Inflammation area, and Genetics and metabolic therapeutic area; the Partner Products segment offers about 40 pharmaceuticals within hematology, oncology and emergency medicines, and the ReFacto Manufacturing segment. The Company has subsidiaries in Sweden, Denmark, Finland, Norway, United Kingdom and France, among others. On September 9, 2013, the Company acquired the full rights to develop and commercialize Kineret (anakinra) from Amgen, the biotechnology company based in the United States.

Price
Delayed
$21.15
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Average)

Today's volume of 100 shares is on pace to be in-line with BIOVF's 10-day average volume of 100 shares.

100
  • Prev Close
    21.15
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    100
  • Last (time)
    3:55p ET 11/30/22
  • Last (size)
    100
  • 52-Wk Range
    18.25 - 24.50
    LowHigh
  • (04/07/22 - 10/11/22)
    15.89%
  • 78.8%
  • Market Cap
    6.3B
  • Shares Outstanding
    296.0M
  • 8.37
  • 27.13x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.3
  • --
  • --

Latest News

No articles or videos found.

Events

There are no calendar events for BIOVF.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.